180 Life Sciences Corp logo

180 Life Sciences Corp

NEW
NAS:ATNF (USA)   Ordinary Shares
$ 1.11 +0.010 (+0.91%) 12:08 AM EST
At Loss
P/B:
0.30
Volume:
15.35K
Avg Vol (2M):
80.30K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
15.35K
At Loss
Avg Vol (2M):
80.30K

Business Description

180 Life Sciences Corp logo
180 Life Sciences Corp
NAICS : 325412 SIC : 2834
ISIN : US68236V2034

Share Class Description:

ATNF: Ordinary Shares
Description
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
Name Current Vs Industry Vs History
Cash-To-Debt 0.06
Equity-to-Asset 0.36
Debt-to-Equity 0.87
Debt-to-EBITDA -1.09
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 33.9
3-Year EPS without NRI Growth Rate 41.7
3-Year FCF Growth Rate 29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.19
Quick Ratio 0.19
Cash Ratio 0.03

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -97.9
Shareholder Yield % -17.7
Name Current Vs Industry Vs History
ROE % -748.68
ROA % -55.67
ROIC % -131.58
3-Year ROIIC % 11.2
ROCE % -416.53

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 0.3
EV-to-EBIT -2.13
EV-to-EBITDA -2.19
EV-to-Forward-Revenue 1.7
EV-to-FCF -2.38
Earnings Yield (Greenblatt) % -46.95
FCF Yield % -76.25

Financials (Next Earnings Date:2025-05-15 Est.)

ATNF's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ATNF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

180 Life Sciences Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -4.815
Beta 0.57
3-Year Sharpe Ratio -1.56
3-Year Sortino Ratio -1.99
Volatility % 161.2
14-Day RSI 41
14-Day ATR ($) 0.086936
20-Day SMA ($) 1.140755
12-1 Month Momentum % -52.71
52-Week Range ($) 0.98 - 17.75
Shares Outstanding (Mil) 3.18

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

180 Life Sciences Corp Filings

Filing Date Document Date Form
No Filing Data

180 Life Sciences Corp Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

180 Life Sciences Corp Frequently Asked Questions

What is 180 Life Sciences Corp(ATNF)'s stock price today?
The current price of ATNF is $1.11. The 52 week high of ATNF is $17.75 and 52 week low is $0.98.
When is next earnings date of 180 Life Sciences Corp(ATNF)?
The next earnings date of 180 Life Sciences Corp(ATNF) is 2025-05-15 Est..
Does 180 Life Sciences Corp(ATNF) pay dividends? If so, how much?
180 Life Sciences Corp(ATNF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1